NCT03033641

FIND CAN Trial: "CF-172"

Feasibility of the CARTOFINDER™ 4D LAT Algorithm to Identify Ablation Target in Subjects With Atrial Fibrillation (FIND CAN Trial: "CF-172")

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (estimated)
• Sponsor: Biosense Webster, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this feasibility study is to further explore characteristics of ablation targets identified by CARTOFINDER 4D LAT Algorithm in subjects with persistent atrial fibrillation and to assess the acute outcome of CARTOFINDER Guided Ablation in terms of the termination of atrial fibrillation to either Normal Sinus Rhythm or Atrial Tachycardia.

Conditions

• Persistent Atrial Fibrillation

Interventions

Type	Name	Description
DEVICE	Ablation procedure	All enrolled subjects who have ablation targets identified will undergo CARTOFINDER guided ablation (CFGA) followed by PVI. Subjects will be followed per the protocol schedule. Subjects who have no ablation target identified on the baseline CARTOFINDER map will undergo ablation per the institution's standard of care and be followed for 7 days for safety monitoring, then exit from the study.

Timeline

• Start date: 2016-12-05
• Primary completion: 2017-05-04
• Completion: 2017-08-30
• First posted: 2017-01-27
• Last updated: 2025-02-03